0001628280-20-014661.txt : 20201021
0001628280-20-014661.hdr.sgml : 20201021
20201021165831
ACCESSION NUMBER: 0001628280-20-014661
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201020
FILED AS OF DATE: 20201021
DATE AS OF CHANGE: 20201021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stewart Murray
CENTRAL INDEX KEY: 0001723450
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38295
FILM NUMBER: 201250986
MAIL ADDRESS:
STREET 1: C/O NOVELION THERAPEUTICS INC.
STREET 2: 1800-510 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6B OM3
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: X4 Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0001501697
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273181608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
BUSINESS PHONE: 857-529-8300
MAIL ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
FORMER COMPANY:
FORMER CONFORMED NAME: Arsanis, Inc.
DATE OF NAME CHANGE: 20100920
4
1
wf-form4_160331389771325.xml
FORM 4
X0306
4
2020-10-20
0
0001501697
X4 Pharmaceuticals, Inc
XFOR
0001723450
Stewart Murray
C/O X4 PHARMACEUTICALS, INC.
61 NORTH BEACON STREET, 4TH FLOOR
BOSTON
MA
02134
1
0
0
0
Stock Option (right to buy)
7.27
2020-10-20
4
A
0
10000
0
A
2030-10-19
Common Stock
10000.0
10000
D
33.3333% of the shares subject to the option shall vest on October 20, 2021, with the remainder vesting in equal monthly installments of 2.7777% of the shares subject to the option until the 36-month anniversary of the date of the grant, subject to the Reporting Person's continued services as a director through each applicable vesting date.
Derek M. Meisner, attorney-in-fact
2020-10-21